CIK 0001091596 · Non-accelerated filer<br>Smaller reporting company
Nuo Therapeutics, Inc.
Sign in to watch- Ticker
- AURX
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233011702
- Phone
- 832-236-9060
- Business address
- 8285 EL RIO, SUITE 190, HOUSTON, TX, 77054
- Former names
- Nuo Therapeutics, Inc, CYTOMEDIX INC, AUTOLOGOUS WOUND THERAPY INC, AUTOLOGOUS WOUND TRERAPY INC
- Open-market buys, last 90 days
- $9,539
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-05 | JORDEN DAVID EMERSON CEO/CFO | Grant or award | +13,245 | $1.10 | $15K | 2,085,000 |
| 2026-05-29 | Pittman Scott M. Director | Grant or award · Interim Warrant (right to buy) | +17,450 | $1.50 | $26K | 17,450 |
| 2026-05-29 | Pittman Scott M. Director | Returned to the company · Second Warrant (right to buy) | −36,750 | $1.50 | $55K | 0 |
| 2026-05-29 | Pittman Scott M. Director | Returned to the company · Prepayment Warrant (right to buy) | −7,516 | $1.50 | $11K | 0 |
| 2026-05-29 | Pittman Scott M. Director | Grant or award · Second Restated Warrant (right to buy) | +17,500 | $1.50 | $26K | 0 |
| 2026-05-29 | Pittman Scott M. Director | Grant or award · Prepayment Restated Warrant (right to buy) | +7,333 | $1.50 | $11K | 0 |
| 2026-01-23 | Pittman Scott M. Director | Grant or award · Initial Warrant (right to buy) | +30,050 | $1.50 | $45K | 30,050 |
| 2026-01-23 | Pittman Scott M. Director | Grant or award · Second Warrant (right to buy) | +36,750 | $1.50 | $55K | 0 |
| 2026-01-23 | Pittman Scott M. Director | Grant or award · Prepayment Warrant (right to buy) | +7,516 | $1.50 | $11K | 0 |
| 2026-01-23 | Pittman Scott M. Director | Grant or award · Commitment Warrants (right to buy) | +2,050 | $1.50 | $3K | 0 |
| 2026-01-23 | Pittman Scott M. Director | Grant or award · Origination Initial Warrants (right to buy) | +1,333 | $1.50 | $2K | 0 |
| 2026-01-23 | Pittman Scott M. Director | Grant or award · Capital Initial Warrants (right to buy) | +26,667 | $1.50 | $40K | 0 |
| 2026-01-23 | Pittman Scott M. Director | Grant or award · Origination Second Warrants (right to buy) | +1,750 | $1.50 | $3K | 0 |
| 2026-01-23 | Pittman Scott M. Director | Grant or award · Capital Second Warrants (right to buy) | +35,000 | $1.50 | $53K | 0 |
| 2026-01-23 | Pittman Scott M. Director | Grant or award · Prepayment Warrants (right to buy) | +7,516 | $1.50 | $11K | 0 |
| 2026-01-01 | JORDEN DAVID EMERSON CEO/CFO | Option exercise | +125,000 | $0.40 | $50K | 2,071,755 |
| 2026-01-01 | JORDEN DAVID EMERSON CEO/CFO | Shares withheld for taxes | −25,381 | $1.97 | $50K | 2,046,374 |
| 2025-12-31 | WINZER C ERIC Director | Option exercise · Option to purchase common stock | −68,750 | 0 | ||
| 2025-12-17 | WINZER C ERIC Director | Option exercise | +68,750 | $0.40 | $28K | 186,404 |
| 2025-12-17 | WINZER C ERIC Director | Shares withheld for taxes | −13,750 | $2.00 | $28K | 172,654 |
Page 2 of 17 · 326 trades